Welcome to our dedicated page for Nevro news (Ticker: NVRO), a resource for investors and traders seeking the latest updates and insights on Nevro stock.
Nevro Corp. develops medical-device technologies for chronic pain treatment, centered on its proprietary 10 kHz Therapy and HFX spinal cord stimulation platform. Company updates commonly cover Senza, Senza II, Senza Omnia, HFX iQ, HFX Coach support services, and Nevrocloud physician insights for pain management and practice support.
News about Nevro also includes regulatory and product developments for spinal cord stimulation systems, clinical and publication updates for sacroiliac joint pain products such as the Nevro1 SI Joint Fusion System, and operating results for its U.S. and international business. Recurring corporate announcements include revenue guidance, preliminary financial results, employee inducement equity grants under NYSE rules, and other capital-structure or governance disclosures tied to its public-company status.
Nevro Corp. (NYSE: NVRO) will participate in the BofA Securities 2024 Healthcare Conference on May 14, 2024, presenting comprehensive pain treatment solutions. A webcast of the event will be available on the company's website.
Nevro Corp. reported its first-quarter 2024 financial results along with additional restructuring steps to boost profitability. The company raised its adjusted EBITDA guidance, reaffirmed revenue guidance for 2024, and promoted Christofer Christoforou to COO. Revenue grew to $101.9 million, with a net loss from operations of $35.8 million and adjusted EBITDA loss of $9.6 million. The company's improved gross margin, operating expenses, and cash position were highlighted. Full-year revenue guidance stands at $435 million to $445 million, with adjusted EBITDA guidance revised to a range of negative $5 million to positive $2 million for 2024.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.